New Perspectives on Machine Learning in Drug Discovery

Author(s): Simona Musella, Giulio Verna, Alessio Fasano, Simone Di Micco*

Journal Name: Current Medicinal Chemistry

Volume 28 , Issue 32 , 2021


Become EABM
Become Reviewer
Call for Editor

Abstract:

Artificial intelligence methods, in particular, machine learning, has been playing a pivotal role in drug development, from structural design to the clinical trial. This approach is harnessing the impact of computer-aided drug discovery due to large available data sets for drug candidates and its new and complex manner of information interpretation to identify patterns for the study scope. In the present review, recent applications related to drug discovery and therapies are assessed, and limitations and future perspectives are analyzed.

Keywords: Machine learning, artificial intelligence, drug repurposing, virtual screening, ADMET, synthesis planning, personalized medicine, drug design.

Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 28
ISSUE: 32
Year: 2021
Published on: 11 November, 2020
Page: [6704 - 6728]
Pages: 25
DOI: 10.2174/0929867327666201111144048
Price: $65

Article Metrics

PDF: 316